Position in HLN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$132,316,352
-$14,575,573 QoQ
Shares Held
14,181,817
-3.4% QoQ
Ownership
0.322%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#8
of 639 holders
Holding Since
Sep 2022
7 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $921,160,135 across 28 Drug Manufacturers - Specialty & Generic names. HLN ranks #3 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,137,442 | $225,456,582 | |
| 2 | VTRS |
Viatris Inc
|
8,371,218 | $132,934,941 | |
| 3 | HLN |
Haleon plc
This page
|
14,181,817 | $132,316,352 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,642,086 | $67,374,788 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
957,514 | $61,233,020 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
3,732,924 | $59,838,771 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
562,016 | $46,523,684 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
1,872,157 | $46,073,783 |
All Filings in HLN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $132,316,352 | 14,181,817 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $146,891,925 | 14,674,518 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $81,154,880 | 8,027,189 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,630,728 | 181,798 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $25,889,763 | 2,516,012 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $8,922,380 | 935,260 | Shares | Defined | 2025-02-12 | |
| 2022-09-30 | $13,791,663 | 2,264,641 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||